The EPS beat may drive a short-term positive move, but unchanged guidance and declining margins suggest caution. Monitor Q2 results for margin stabilization and progress on divestitures. The $1B buyback authorization partially offsets operational headwinds.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 7 $131.59entry
- T+1 · 6mo ago +0.72%α −0.11% · $132.54
- T+5 · 6mo ago −1.18%α −2.69% · $130.04
- T+20 · 6mo ago −2.31%α −5.44% · $128.56
- T+60 · 4mo ago +3.89%α +1.78% · $136.71
Price Chart
How similar events traded
Executive Summary
Teleflex Q1 2026 adjusted EPS of $1.39 beat consensus by 14%, and pro forma adjusted constant currency revenue grew 5.1% year-over-year, in line with full-year guidance. However, GAAP EPS was a loss of ($0.11) due to restructuring costs, adjusted operating margin compressed 510 bps to 18.1%, and adjusted EPS declined 3.5% YoY. Full-year guidance was maintained, not raised, tempering the beat's impact.
Key Financial Metrics
Key Facts
- Adjusted diluted EPS from continuing ops $1.39 vs consensus $1.22 (14% beat)
- Revenue $548.3M vs consensus $537.6M (2% beat, in line per threshold)
- Pro forma adjusted constant currency revenue growth 5.1% (within 4.5%-5.5% guidance)
- GAAP EPS $(0.11) from continuing ops due to $79.2M in pre-tax adjustments
- Adjusted operating margin 18.1%, down from 23.2% in Q1 2025
- Full-year 2026 guidance maintained: adjusted EPS $6.25-$6.55, pro forma revenue growth 4.5%-5.5%
- Company expects strategic divestitures to close in H2 2026; $1B share repurchase to begin in Q2
Financial Impact
Q1 adjusted EPS beat by $0.17 (14%), but annual guidance unchanged; stranded costs of $90M weigh on margins
Risk Factors
- Divestiture delays or worse-than-expected proceeds
- Stranded costs exceeding $90M annual estimate
- Further margin compression from tariffs and supplier disruptions
- Integration costs from Vascular Intervention acquisition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000096943-26-000048 |
| Exhibit: exhibit992to5-7x2026req1.htm | 0000096943-26-000048 |
| Document: tfx-20260507.htm | 0000096943-26-000048 |
| Document: 0000096943-26-000048-index-headers.html | 0000096943-26-000048 |
| Document: 0000096943-26-000048-index.html | 0000096943-26-000048 |
| Document: 0000096943-26-000048.txt | 0000096943-26-000048 |
| 8-K Data (Synthetic) | 0000096943-26-000048 |
Track record
11 reports on TFX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $154.69 Now $155.10 +0.27% settles Nov 23
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $152.15 to $153.15 Now $155.10 +1.94% ▲ +0.66% −2.63% vs SPY
- Aug 6, 202614w ago 8-K Mixed 6/10 Entry $138.89 to $137.37 Now $155.10 +11.67% ▼ −1.09% −2.31% vs SPY
- Jul 2, 202619w ago Court Ruling Bullish 6/10 Entry $133.99 to $134.04 Now $155.10 +15.75% ▲ +0.04% −0.89% vs SPY
- Jun 22, 202621w ago Institutional Cluster Mixed 4/10 Entry $121.67 to $129.86 Now $155.10 +27.48% ▲ +6.73% +8.80% vs SPY
- Jun 15, 202622w ago 8-K Neutral 4/10 Entry $127.87 to $124.26 Now $155.10 +21.30% ▼ −2.82% −0.59% vs SPY
- Jun 9, 202622w ago 8-K Neutral 2/10 Entry $132.15 to $127.87 Now $155.10 +17.37% ▼ −3.24% −6.67% vs SPY
- Jun 1, 202624w ago 8-K Neutral 4/10 Entry $127.31 to $129.84 Now $155.10 +21.82% ▲ +1.98% +4.73% vs SPY
- May 27, 202624w ago 8-K Neutral 4/10 Entry $128.90 to $131.04 Now $155.10 +20.32% ▲ +1.66% +1.34% vs SPY
- May 7, 202627w ago 8-K Mixed 6/10 Viewing Entry $131.59 to $130.04 Now $155.10 +17.86% ▼ −1.18% −2.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers